Literature DB >> 7037834

Detection of rubella antibodies by hemagglutination inhibition, indirect fluorescent-antibody test, and enzyme-linked immunosorbent assay.

M V Zartarian, G Friedly, E M Peterson, L M de la Maza.   

Abstract

Using hemagglutination inhibition (HAI) as a reference method, 292 (40 nonimmune, 252 immune) human serum samples were tested by indirect fluorescent antibody (IFA) and enzyme-linked immunosorbent assay (ELISA) for immune status and quantitation of rubella antibodies. The overall agreement with HAI for immune status was 99.7% (291/292) with IFA and 98.6% (288/292) with ELISA. Two specimens (0.7%, 2/292), negative by HAI, were equivocal by ELISA. Initially a 6.5% (19/292) overall disagreement was obtained for immune status evaluation between HAI and IFA, which was reduced to 0.3% (1/292) upon repeat testing. All of these samples were near the immune/nonimmune cutoff point (95 samples), reflecting an initial disagreement of 20% (19/95) in this category (HAI titers less than 1:20). Likewise, an initial overall disagreement of 4.5% (13/292) was obtained between HAI and ELISA which was reduced to 0.7% (2/292) upon repeated testing. Eleven of the 13 samples were near the immune/nonimmune cutoff point, reflecting an initial disagreement of 11.6% (11/95) with sera having an HAI antibody titer of less than 1:20. Quantitation of rubella antibodies by IFA showed an overall correlation with HAI of 86.6% within less than twofold titer and 99.3% within less than fourfold titers. In testing the ability of ELISA to quantitate antibody, a correlation coefficient (r) of 0.996 was obtained by plotting the measured average optical density (405 nm) of ELISA against the corresponding log of HAI titer. Both IFA and ELISA showed good correlation with HAI for immune status evaluation and for quantitation of rubella antibodies. Technically the HAI was the most cumbersome to perform, whereas IFA was the least technically demanding. Originally, 308 samples were tested; 16 samples (5.2%) could not be evaluated by IFA because of a high level of nonspecific fluorescence. The strict requirement of controlling the temperature range (23 to 24 degrees C) during substrate hydrolysis proved to be a problem with the ELISA test in our laboratory.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037834      PMCID: PMC274013          DOI: 10.1128/jcm.14.6.640-645.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies.

Authors:  B F Vestergaard; P C Grauballe
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-08

2.  False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure.

Authors:  G Haukenes; H Blom
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

3.  A comparison of three tests for rubella antibody screening.

Authors:  P Morgan-Capner; H J Pullen; J R Pattison; D E Bidwell; A Bartlett; A Voller
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

4.  Enzyme-linked immunosorbent assay for determination of rubella IgG antibodies.

Authors:  M Vejtorp
Journal:  Acta Pathol Microbiol Scand B       Date:  1978-12

5.  Evaluation and comparison of two assays for detection of immunity to rubella infection.

Authors:  J P Brody; J H Binkley; S A Harding
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

6.  A solid-phase enzyme-linked immunosorbent assay (ELISA) for detection of antibody to rubella virus.

Authors:  S M Garland; S A Locarnini; I D Gust
Journal:  Pathology       Date:  1979-07       Impact factor: 5.306

7.  Further investigation of the specificity and sensitivity of ELISA for rubella antibody screening.

Authors:  D E Bidwell; S M Chantler; P Morgan-Capner; J R Pattison
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

8.  A simple method for detecting antibodies to rubella.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1975-08

9.  Variables of the rubella hemagglutination-inhibition test system and their effect on antigen and antibody titers.

Authors:  N J Schmidt; E H Lennette
Journal:  Appl Microbiol       Date:  1970-03

10.  A direct enzyme-linked immunosorbent assay (ELISA) for detection of antibodies for rubella virus in human sera.

Authors:  T J Cleary; A Cid; B Ellis; H Malkus; T Noto; S Halbert; A Castro
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-02
View more
  11 in total

1.  Functional capacity of immunoglobulin G preparations and the F(ab')2 split product.

Authors:  R W Steele; R W Steele
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

2.  Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory.

Authors:  A L Truant; B L Barksdale; T W Huber; L B Elliott
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

3.  Evaluation of a latex agglutination test for detection of antibodies to rubella virus in selected sera.

Authors:  S Freeman; L Clark; N Dumas
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

4.  Multicenter evaluation of a 1-h enzyme-linked immunosorbent assay for rubella serology.

Authors:  W L Boteler; K J Barnes; E Buimovici-Klein; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

5.  Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

6.  Determination of immune status in patients with low antibody titers for rubella virus.

Authors:  S L Fayram; S Akin; S L Aarnaes; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  New passive hemagglutination assay kit that uses hemagglutinin-sensitized erythrocytes for detection of rubella antibodies.

Authors:  S R Coates; R D Madsen; D F Rippe
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

8.  Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

9.  Fluoroimmunoassay for detection of rubella-specific immunoglobulin M: comparison with indirect enzyme immunoassay and mu-chain capture.

Authors:  J M Echevarria; F de Ory; R Najera
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

10.  Fluorescence immunoassay and passive latex agglutination as alternatives to hemagglutination inhibition for determining rubella immune status.

Authors:  S L Fayram; A Nakasone; S Aarnaes; M Zartarian; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.